Each has different ingredient profiles and varying levels of evidence
NICE Technology Appraisal guidance (TA875 for semaglutide/Wegovy and TA664 for liraglutide/Saxenda) recommends these medications for weight management in adults with: A body mass index (BMI) of at least 35 kg/m and At least one weight-related comorbidity (such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or non-alcoholic fatty liver disease) For liraglutide (Saxenda), NICE TA664 specifies additional criteria including prediabetes (HbA1c 42-47 mmol/mol or fasting plasma glucose 5.5-6.9 mmol/L) or high risk of cardiovascular disease
Esto crea una oportunidad para que las marcas reformulen con endulzantes de etiqueta limpia que brinden satisfaccin sin agregar azcares en exceso
Hager, M
Support for Skin Appearance GLP-1 support formulations that target skin appearance often contain nutraceuticals that support collagen production, skin hydration, elasticity, and overall skin health, including the following : Collagen peptides Specific collagen peptides have been studied for their role in supporting the bodys natural collagen production and aspects of skin appearance, including skin elasticity, moisture, wrinkle appearance, cellulite appearance, and hair thickness
All these micro-damages with time would accumulate, thus leading to chronic and ultimately, end-stage kidney disease (ESKD)